Startups

Director of Clinical Service Provider Contracting Early Stage

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

The Director of Clinical Service Provider Contracting, Early Stage, will lead Service Provider sourcing, requests for information/proposal (RFIs/RFPs), contracting, and governance for assigned early-stage clinical programs. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree in life sciences, business, or a related field and at least 15 years of relevant biotechnology, pharmaceutical, or clinical research experience, or an equivalent combination of education and experience
  • At least 9 years in a management role overseeing individuals in a high performing team environment
  • Minimum of 10 years of direct clinical business operations, outsourcing, and vendor governance experience in a CRO, biotechnology, or pharmaceutical organization, with demonstrated leadership of cross-functional initiatives or teams
  • Experience supporting early-stage oncology studies, including first-in-human, dose-escalation, or dose-expansion programs, and translating evolving study needs into contractual scope
  • Proven ability to lead RFIs/RFPs, evaluate proposals, negotiate complex Service Provider agreements, and manage change orders and contractual obligations
  • Experience establishing Service Provider governance, assessing performance, resolving issues, and coordinating with Legal, Finance, Quality, and study teams
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Director of Clinical Service Provider Contracting, Early Stage, will lead Service Provider sourcing, requests for information/proposal (RFIs/RFPs), contracting, and governance for assigned early-stage clinical programs.

This role will partner with Clinical Operations and study teams to define service requirements and establish agreements that support first-in-human, dose-escalation, and...

Read the full posting on Revolution Medicines's site ↗

Clinical Operations

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.